Risk Predictors of Stroke and Mortality Following Ablation For Atrial Fibrillation: the California experience 2005-2009
Atrial Fibrillation Friday, July 25th, 2014Heart Rhythm Journal: July 15, 2014
Background
Ablation (ABL) is a second line therapy for the management of atrial fibrillation (AF). Single center studies have demonstrated the safety and efficacy of ABL, however the low event rates render it difficult to assess predictors of major adverse events.
Objectives
To determine the population-based incidence of data and risk factors for both stroke < 30 days and death after AF ABL. Read More
